Plenteous Pharmaceuticals Limited, a active public limited company, was established on 11 December 2008 in Delhi, Delhi, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24232DL2008PLC185686. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 13 professional, Its leadership includes Dhara Ballabh Tiwari (Director), Pooja Sharma (Whole-Time Director), Neetika Goel (Director). Past directors included Harish Kumar, Sanjay Chandra Varma, Mahesh Malhotra. It holds ₹5.00 Cr open charges and ₹42.00 Cr settled loans. Its latest AGM occurred on 11 May 2025, with the balance sheet filed on 31 March 2025. It is based at 210, 2Nd Floor, Mohan Place, Lsc Block- C, Saraswati Vihar, Delhi, Delhi, 110034.
U24232DL2008PLC185686
185686
11 December 2008
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Plenteous Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhara Ballabh Tiwari | Director | 07 Dec 2013 | Current |
| Pooja Sharma | Whole-Time Director | 24 Nov 2017 | Current |
| Neetika Goel | Director | 06 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Dec 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 24 Nov 2017 | Past |
| Pramod Abcsdd | Director | 24 Mar 2022 | Past |
| Pramod Abcsdd | Director | 02 Mar 2009 | Past |
| Pramod Abcsdd | Director | 02 Mar 2009 | Past |
| Pramod Abcsdd | Additional Director | 17 Jun 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Plenteous Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.77% decrease. The company also saw a substantial fall in profitability, with a 510.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 119%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Plenteous Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹420,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2019 | Hdfc Bank Limited | ₹5.00 Cr | Open |
| 10 Mar 2023 | Jp Morgan Chase Bank, N.A. | ₹40.00 Cr | Satisfied |
| 12 Dec 2011 | Icici Bank Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Plenteous Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Plenteous Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plenteous Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Plenteous Pharmaceuticals Limited last Annual general meeting of members was held on 11 May 2025 as per latest MCA records. was recorded as a recent event.
A charge registered on 10 Mar 2023 via Charge ID 100687919 with Jp Morgan Chase Bank, N.A. was fully satisfied on 24 Apr 2025. was recorded as a recent event.
Progress on Plenteous Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
The activity Neetika Goel was appointed as a Director was appointed as a Director on 06 Nov 2024 & has been associated with this company since 1 year 26 days . was completed.
A charge with Jp Morgan Chase Bank, N.A. amounted to Rs. 400.00 M with Charge ID 100687919 was registered on 10 Mar 2023. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 50.00 M with Charge ID 100273798 was registered on 29 Jun 2019. was documented.
The CIN of Plenteous Pharmaceuticals Limited is U24232DL2008PLC185686.
Plenteous Pharmaceuticals Limited is headquartered at 210, 2Nd Floor, Mohan Place, Lsc Block- C, Saraswati Vihar, Delhi, Delhi, 110034.
Plenteous Pharmaceuticals Limited was incorporated on 11 December 2008.
The current directors of Plenteous Pharmaceuticals Limited are
The primary industry of Plenteous Pharmaceuticals Limited is Hospital And Medical Care.
Plenteous Pharmaceuticals Limited is unlisted.
The authorized capital of Plenteous Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Plenteous Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX